Home » Authors » Trista Morrison

Articles by Trista Morrison

Cell Therapeutics Raising $37.2M; Abandons Offer to Buy Dor

April 13, 2007

By Trista Morrison

Genaera Restructures Again, To Focus On Obesity Program

April 12, 2007

By Trista Morrison

Genaera Restructures Again, To Focus On Obesity Program

April 12, 2007

By Trista Morrison

Ascenta Raises $50M For Apoptosis Phase II Trials

April 11, 2007

By Trista Morrison

Ascenta Raises $50M For Apoptosis Phase II Trials

April 11, 2007

By Trista Morrison

EPA Awards $111M In BioPharma Contracts

April 10, 2007

By Trista Morrison

EPA Awards $111M In BioPharma Contracts

April 10, 2007

By Trista Morrison

Blanca Partners With SRI To Push Preclinical Work on 2 Antibiotics

April 6, 2007

By Trista Morrison

Blanca Partners With SRI To Push Preclinical Work on 2 Antibiotics

April 6, 2007

By Trista Morrison

Roche Ends 10-Year Court Fight By Acquiring BioVeris For $600M

April 5, 2007

By Trista Morrison

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 16, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...